UBS Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.42M | Sell |
296,970
-29,492
| -9% | -$804K | ﹤0.01% | 3425 |
|
|
2025
Q4 | $8.87M | Sell |
326,462
-89,985
| -22% | -$2.37M | ﹤0.01% | 3420 |
|
|
2025
Q3 | $10.8M | Sell |
416,447
-424,799
| -50% | -$9.84M | ﹤0.01% | 3213 |
|
|
2025
Q2 | $17.1M | Sell |
841,246
-626,994
| -43% | -$12.2M | ﹤0.01% | 2538 |
|
|
2025
Q1 | $26.6M | Buy |
1,468,240
+1,078,443
| +277% | +$24.1M | 0.01% | 2078 |
|
|
2024
Q4 | $9.85M | Buy |
389,797
+223,200
| +134% | +$6.06M | ﹤0.01% | 3062 |
|
|
2024
Q3 | $5.66M | Buy |
166,597
+6,001
| +4% | +$229K | ﹤0.01% | 2951 |
|
|
2024
Q2 | $5.94M | Sell |
160,596
-95,752
| -37% | -$3.61M | ﹤0.01% | 2689 |
|
|
2024
Q1 | $10.8M | Buy |
256,348
+98,256
| +62% | +$4.03M | ﹤0.01% | 2206 |
|
|
2023
Q4 | $6.27M | Buy |
158,092
+136,897
| +646% | +$4.03M | ﹤0.01% | 2529 |
|
|
2023
Q3 | $583K | Buy |
21,195
+20,418
| +2,628% | +$640K | ﹤0.01% | 4537 |
|
|
2023
Q2 | $26.4K | Sell |
777
-60,098
| -99% | -$2.03M | ﹤0.01% | 6759 |
|
|
2023
Q1 | $2.19M | Sell |
60,875
-58,368
| -49% | -$2.52M | ﹤0.01% | 3324 |
|
|
2022
Q4 | $5.31M | Buy |
119,243
+82,315
| +223% | +$2.94M | ﹤0.01% | 2450 |
|
|
2022
Q3 | $1.04M | Sell |
36,928
-37,350
| -50% | -$1.15M | ﹤0.01% | 3727 |
|
|
2022
Q2 | $2M | Sell |
74,278
-86,501
| -54% | -$2.51M | ﹤0.01% | 3148 |
|
|
2022
Q1 | $5.48M | Buy |
160,779
+30,189
| +23% | +$965K | ﹤0.01% | 2448 |
|
|
2021
Q4 | $5.05M | Buy |
130,590
+83,264
| +176% | +$3.63M | ﹤0.01% | 2807 |
|
|
2021
Q3 | $2.56M | Buy |
47,326
+27,013
| +133% | +$1.27M | ﹤0.01% | 3371 |
|
|
2021
Q2 | $679K | Sell |
20,313
-34,536
| -63% | -$948K | ﹤0.01% | 4500 |
|
|
2021
Q1 | $1.13M | Buy |
54,849
+52,091
| +1,889% | +$1.2M | ﹤0.01% | 4128 |
|
|
2020
Q4 | $48K | Buy |
2,758
+1,188
| +76% | +$21.4K | ﹤0.01% | 6215 |
|
|
2020
Q3 | $23K | Buy |
1,570
+980
| +166% | +$11.5K | ﹤0.01% | 6193 |
|
|
2020
Q2 | $7K | Sell |
590
-307
| -34% | -$1.36K | ﹤0.01% | 7212 |
|
|
2020
Q1 | $1K | Sell |
897
-618
| -41% | -$1.4K | ﹤0.01% | 7744 |
|
|
2019
Q4 | $3K | Sell |
1,515
-3,232
| -68% | -$7.5K | ﹤0.01% | 7733 |
|
|
2019
Q3 | $10K | Buy |
4,747
+1,246
| +36% | +$2.88K | ﹤0.01% | 7154 |
|
|
2019
Q2 | $10K | Buy |
3,501
+3,300
| +1,642% | +$11.2K | ﹤0.01% | 7057 |
|
|
2019
Q1 | $1K | Sell |
201
-4,345
| -96% | -$22.9K | ﹤0.01% | 7524 |
|
|
2018
Q4 | $14K | Buy |
4,546
+4,340
| +2,107% | +$21.3K | ﹤0.01% | 7030 |
|
|
2018
Q3 | $1K | Sell |
206
-4,188
| -95% | -$29.3K | ﹤0.01% | 7821 |
|
|
2018
Q2 | $33K | Buy |
4,394
+2,072
| +89% | +$27.7K | ﹤0.01% | 6309 |
|
|
2018
Q1 | $81K | Sell |
2,322
-36
| -2% | -$1.4K | ﹤0.01% | 5362 |
|
|
2017
Q4 | $100K | Sell |
2,358
-2,733
| -54% | -$117K | ﹤0.01% | 5349 |
|
|
2017
Q3 | $219K | Buy |
5,091
+708
| +16% | +$26.5K | ﹤0.01% | 4781 |
|
|
2017
Q2 | $162K | Sell |
4,383
-489
| -10% | -$21.6K | ﹤0.01% | 4869 |
|
|
2017
Q1 | $264K | Sell |
4,872
-7,864
| -62% | -$409K | ﹤0.01% | 4468 |
|
|
2016
Q4 | $677K | Buy |
12,736
+2,720
| +27% | +$155K | ﹤0.01% | 3886 |
|
|
2016
Q3 | $607K | Sell |
10,016
-5,573
| -36% | -$347K | ﹤0.01% | 3781 |
|
|
2016
Q2 | $1.03M | Buy |
15,589
+11,054
| +244% | +$702K | ﹤0.01% | 3355 |
|
|
2016
Q1 | $257K | Sell |
4,535
-12,499
| -73% | -$1.41M | ﹤0.01% | 4318 |
|
|
2015
Q4 | $4.01M | Buy |
17,034
+12,254
| +256% | +$2.67M | ﹤0.01% | 2155 |
|
|
2015
Q3 | $756K | Sell |
4,780
-792
| -14% | -$224K | ﹤0.01% | 3587 |
|
|
2015
Q2 | $2.11M | Buy |
5,572
+247
| +5% | +$98.1K | ﹤0.01% | 2923 |
|
|
2015
Q1 | $2.23M | Buy |
5,325
+1,457
| +38% | +$521K | ﹤0.01% | 2832 |
|
|
2014
Q4 | $1.06M | Buy |
+3,868
| New | +$962K | ﹤0.01% | 3522 |
|
Other funds holding CLDX
KCM
VCM
CC
EP